Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. RIP former Evalve CEO Powell
Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott, died this month in a motorbike accident in northern Thailand, her family said yesterday.
Powell oversaw the development of the MitraClip device, a transcatheter alternative to open heart surgery for treating leaky mitral valves. Her sister, Liz McDermott, led the clinical and regulatory teams at Evalve. Read more
2. Australian PE shop acquires Simplify Medical
Simplify Medical said it was recently acquired by Australian private equity shop M.H. Carnegie for an undisclosed amount, as it gears up for a U.S. clinical trial of its MRI-safe artifical cervical disc.
“We invested in Simplify Medical because we believe they have a better option for treating patients in a growing market in spine. We are working with the company to accomplish their mission of providing non-metallic, MRI-friendly, anatomically appropriate cervical artificial discs to patients worldwide,” M.H. Carnegie managing director Mark Carnegie said in a statement. Read more
1. CRM: Boston Scientific’s gain is St. Jude Medical’s loss
FDA approval of the Emblem S-ICD made by Boston Scientific puts the company in place to take market share in the cardiac rhythm management space from rivals St. Jude Medical and Medtronic, Wells Fargo analysts said.
Revenues from St. Jude’s CardioMEMS device, which that company is counting on, won’t be enough to offset the share losses from Boston’s Emblem device, the analysts wrote in a note to investors. Read more
